IgA Antibodies
Immunology
Description
Deficiency of immunoglobulin A (IgA) is the commonest primary immunodeficiency disease affecting humans. A subpopulation of IgA deficient people have anti-IgA antibodies. Some of these patients may be at risk of serious or life threatening reactions to transfused blood or blood products that contain IgA. These reactions are frequently anaphylactic in nature and are often associated with anti-IgA antibodies. Notably, serious reactions in the absence of detected anti-IgA antibody have also been reported [1].
Indications
To delineate a subgroup of IgA deficient patients who may be at risk of serum sickness like reaction if given infusions of blood products containing IgA.
Sample Type
2mL Serum (Gel 5mL Yellow tube)
Reference Range
Negative
Turnaround Time
Within 2 weeks
Testing Frequency
As required
References
Eijkhout HW, van den Broek PJ, and van der Meer JW.Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med. 2003. 61(6):213-217. [Ref 1]Cable R, et al. Practice guidelines for blood transfusion. 2nd Edition. 2007. American National Red Cross.
See Also
Immunoglobulins
Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.
Your contact for this test
Clare Del-Duca BSc (Hons) Biomedical Science, MSc Pathological Science
Laboratory Manager - Immunology and Protein Reference Unit
You are enquiring about
IgA Antibodies